Know Cancer

or
forgot password
  • cancer clinical trials in rhinelander, WI

  • Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Breast Cancer
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Lung Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Breast Cancer
    Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Leukemia
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Esophageal Cancer, Gastric Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Endometrial Cancer
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Melanoma (Skin)
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Ixabepilone in Treating Patients With Metastatic Prostate Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Prostate Cancer
    Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Lymphoma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Colorectal Cancer
    Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Sexuality and Reproductive Issues, Spiritual Concerns
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Anal Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Gastrointestinal Stromal Tumor
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Esophageal Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Leukemia
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Leukemia
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Brain and Central Nervous System Tumors
    Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Leukemia, Lymphoma
    Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Melanoma (Skin)
    Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Brain and Central Nervous System Tumors, Neurotoxicity
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Home-Based Programs for Improving Sleep in Cancer Survivors
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Cancer Survivor, Fatigue, Psychosocial Effects of Cancer and Its Treatment, Sleep Disorders
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Colorectal Cancer, Precancerous Condition
    Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Lung Cancer
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Breast Cancer
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Kidney Cancer
    Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Lymphoma
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Marshfield Clinic at James Beck Cancer Center
    Rhinelander, Wisconsin 54501
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
    Ministry Medical Group at Saint Mary's Hospital
    Rhinelander, Wisconsin 54501
    Head and Neck Cancer, Mucositis, Oral Complications of Radiation Therapy, Pain